Citadel Advisors’s Marpai, Inc. Class A Common Stock MRAI Stock Holding History

Citadel Advisors’s Portfolio MRAI Stock Details MRAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-15,046	Closed	-$109K	–	14582
2022 Q1	$109K	Buy	+15,046	New	+$137K	﹤0.01%	12206

Other funds holding MRAI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Citadel Advisors's MRAI Position: Q2 2022 in Review

Citadel Advisors sold out of Marpai, Inc. Class A Common Stock (MRAI) in Q2 2022, closing a stake of 15,046 shares — an estimated $109K sold.

Citadel Advisors first reported a position in MRAI in Q1 2022 and held it in 1 quarter. The position peaked at $109K in Q1 2022. 10 funds tracked by Wall St. Rank hold MRAI as of Q2 2022.

Citadel Advisors reported no remaining Marpai, Inc. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
Citadel Advisors sold 15,046 Marpai, Inc. Class A Common Stock shares in Q2 2022, an estimated $109K.
Citadel Advisors first reported a position in Marpai, Inc. Class A Common Stock in Q1 2022 and held it in 1 quarter.
Citadel Advisors's Marpai, Inc. Class A Common Stock position peaked at $109K in Q1 2022.
10 funds tracked by Wall St. Rank held Marpai, Inc. Class A Common Stock as of Q2 2022.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.